Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 11 to 20 of 92

Publication Record

Connections

Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.
Iams WT, Lovly CM
(2018) Cancer Discov 8: 797-799
MeSH Terms: Humans, Medical Oncology, Neoplasms, Precision Medicine, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-ret
Added September 10, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Secondary Malignancies in the Era of High-Precision Radiation Therapy.
Balcer-Kubiczek EK, Eley JG
(2018) Crit Rev Oncog 23: 93-112
MeSH Terms: Animals, Cell Transformation, Neoplastic, Humans, Neoplasms, Neoplasms, Second Primary, Precision Medicine, Radiation, Ionizing, Radiotherapy, Radiotherapy Dosage, Risk Assessment
Added March 30, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association.
Musunuru K, Arora P, Cooke JP, Ferguson JF, Hershberger RE, Hickey KT, Lee JM, Lima JAC, Loscalzo J, Pereira NL, Russell MW, Shah SH, Sheikh F, Wang TJ, MacRae CA, American Heart Association Council on Genomic and Precision Medicine; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council
(2018) Circ Genom Precis Med 11: e000046
MeSH Terms: American Heart Association, Biomedical Research, Cardiovascular Diseases, Electronic Health Records, Genomics, Humans, Interdisciplinary Studies, Precision Medicine, United States
Added April 2, 2019
0 Communities
1 Members
0 Resources
9 MeSH Terms
Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.
Roden DM, Van Driest SL, Wells QS, Mosley JD, Denny JC, Peterson JF
(2018) Circ Res 122: 1176-1190
MeSH Terms: Biological Variation, Individual, Biotransformation, Cardiovascular Agents, Drug Development, Drug-Related Side Effects and Adverse Reactions, Forecasting, Genetic Association Studies, Genetic Predisposition to Disease, Genetic Testing, Genetic Variation, Genomics, Genotyping Techniques, Human Genome Project, Humans, Pharmacogenetics, Precision Medicine, Randomized Controlled Trials as Topic, Risk Assessment, Sample Size
Added March 24, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases.
Chun YW, Durbin MD, Hong CC
(2018) Curr Cardiol Rep 20: 38
MeSH Terms: Cardiovascular Diseases, Cell Differentiation, Gene Editing, Humans, Induced Pluripotent Stem Cells, Models, Biological, Precision Medicine
Added May 1, 2018
1 Communities
0 Members
0 Resources
7 MeSH Terms
Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.
Volpi S, Bult CJ, Chisholm RL, Deverka PA, Ginsburg GS, Jacob HJ, Kasapi M, McLeod HL, Roden DM, Williams MS, Green ED, Rodriguez LL, Aronson S, Cavallari LH, Denny JC, Dressler LG, Johnson JA, Klein TE, Leeder JS, Piquette-Miller M, Perera M, Rasmussen-Torvik LJ, Rehm HL, Ritchie MD, Skaar TC, Wagle N, Weinshilboum R, Weitzel KW, Wildin R, Wilson J, Manolio TA, Relling MV
(2018) Clin Pharmacol Ther 103: 778-786
MeSH Terms: Humans, Pharmacogenetics, Precision Medicine, Research, United States
Added March 14, 2018
0 Communities
2 Members
0 Resources
5 MeSH Terms
Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?
Stack JP, Moslehi J, Sayed N, Wu JC
(2019) Eur Heart J 40: 1764-1770
MeSH Terms: Animals, Antineoplastic Agents, Cardiomyopathies, Cardiotoxicity, Cardiotoxins, Drug Evaluation, Preclinical, Genomics, Humans, Induced Pluripotent Stem Cells, Mice, Models, Biological, Neoplasms, Precision Medicine
Added April 22, 2018
0 Communities
1 Members
0 Resources
13 MeSH Terms
Established, emerging and elusive molecular targets in the treatment of lung cancer.
Gallant JN, Lovly CM
(2018) J Pathol 244: 565-577
MeSH Terms: Animals, Antineoplastic Agents, Biomarkers, Tumor, Clinical Decision-Making, Genetic Predisposition to Disease, Genomics, Humans, Lung Neoplasms, Molecular Targeted Therapy, Pathology, Molecular, Phenotype, Precision Medicine, Predictive Value of Tests, Prognosis
Added September 10, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Translating Knowledge Into Therapy for Acute Kidney Injury.
de Caestecker M, Harris R
(2018) Semin Nephrol 38: 88-97
MeSH Terms: Acute Kidney Injury, Biopsy, Clinical Trials as Topic, Humans, Kidney, Patient Selection, Phenotype, Precision Medicine, Translational Medical Research
Added October 23, 2018
0 Communities
1 Members
0 Resources
9 MeSH Terms
The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development.
Denny JC, Van Driest SL, Wei WQ, Roden DM
(2018) Clin Pharmacol Ther 103: 409-418
MeSH Terms: Big Data, Drug Repositioning, Electronic Health Records, Humans, Pharmacogenetics, Pharmacology, Clinical, Precision Medicine, Randomized Controlled Trials as Topic
Added March 14, 2018
0 Communities
2 Members
0 Resources
8 MeSH Terms